---
schema_version: "secwatch.filing_event.v1"
accession: "0001654954-23-013894"
form_type: "8-K"
ticker: "USBC"
cik: "0001074828"
company_name: "USBC, Inc."
filed_at: "2023-11-08T23:59:59+00:00"
generated_at: "2026-06-08T08:38:07.426768+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Know Labs expands board to 7 with three new directors from IP and diabetes sectors

## Summary
- John Cronin, Larry Ellingson, and Timothy Londergan appointed as independent directors effective Nov 3, 2023.
- Cronin helped boost Know Labs' patent portfolio from 86 to 246 issued, pending or in-process patents in 12 months.
- Ellingson, former Eli Lilly diabetes head, served on Know Labs' advisory board for 4 years prior.
- Londergan, CEO of Tangibly, was named IAM 300 World's Leading IP Strategist 2023.
- New directors receive annual stock option grants and cash retainer of $10,000–$12,500.

## SEC filing metadata
- accession: 0001654954-23-013894
- form_type: 8-K
- ticker: USBC
- cik: 0001074828
- company_name: USBC, Inc.
- filed_at: 2023-11-08T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1074828/000165495423013894/0001654954-23-013894-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1074828/000165495423013894/knwn_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001654954-23-013894
- JSON: https://secwatch.observer/filing/0001654954-23-013894.json
- Plain text: https://secwatch.observer/filing/0001654954-23-013894.txt

## Key facts
- Executive change
  John Cronin was appointed as Director at USBC, Inc..
  - Action: appointed
  - Role: Director
  source text: On November 3, 2023, the Board of Directors (“Board”) of Know Labs, Inc. (the “Company”) appointed Larry K. Ellingson, John Cronin and Timothy M. Londergan, as new non-employee members of the Board.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1074828/000165495423013894/0001654954-23-013894-index.htm
- Executive change
  Larry K. Ellingson was appointed as Director at USBC, Inc..
  - Action: appointed
  - Role: Director
  source text: On November 3, 2023, the Board of Directors (“Board”) of Know Labs, Inc. (the “Company”) appointed Larry K. Ellingson, John Cronin and Timothy M. Londergan, as new non-employee members of the Board.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1074828/000165495423013894/0001654954-23-013894-index.htm
- Executive change
  Timothy M. Londergan was appointed as Director at USBC, Inc..
  - Action: appointed
  - Role: Director
  source text: On November 3, 2023, the Board of Directors (“Board”) of Know Labs, Inc. (the “Company”) appointed Larry K. Ellingson, John Cronin and Timothy M. Londergan, as new non-employee members of the Board.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1074828/000165495423013894/0001654954-23-013894-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.